Please provide your email address to receive an email when new articles are posted on . Miebo (perfluorohexyloctane ophthalmic solution, Bausch + Lomb), an eye drop that prevents tear evaporation, can ...

Please provide your email address to receive an email when new articles are posted on . There is general agreement in ophthalmology that punctal plugs are indicated when first line treatment with ...

A retrospective administrative claims analysis of treatment options for dry eye disease (DED) evaluated treatment patterns and utilization characteristics of patients receiving cyclosporine, punctal ...

A detailed assessment of the current market landscape of novel ocular drug delivery devices, with respect to type of drug delivery device (implants, inserts and punctal plugs), current status of ...

Allogeneic haematopoietic SCT is performed for the treatment of many diseases. One of the major success-limiting factors after transplantation is the development of GvHD, which may lead to severe ...

VANCOUVER, July 28 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced encouraging interim data from an ongoing Phase ...

Punctal plugs (PP) insertion is an effective and reversible method to treat dry eye syndrome (DES) and some other ocular surface diseases. Non-absorbable plugs made of silicon are the most commonly ...

VANCOUVER, British Columbia, Aug. 29, 2011 (GLOBE NEWSWIRE) -- QLT Inc. /quotes/zigman/13615/quotes/nls/qlti QLTI +1.81% /quotes/zigman/13629 CA:QLT +1.99% today ...

BEDFORD, Mass., Oct. 12 Ocular Therapeutix, Inc. announced today the completion of a successful Proof of Principle clinical study with their novel sustained drug delivery moxifloxacin punctum plug.

Over time, several pharmaceutical companies across the world have undertaken various initiatives to develop novel drug delivery devices, such as sustained release implants, ocular inserts and punctal ...